The efficacy and safety of infliximab in patients with ankylosing spondylitis: results of an open-labeled multicenter study

Aim. To evaluate the efficacy and tolerability of the anti-tumor necrosis factor-α infliximab in patients with active ankylosing spondylitis (AS) in a 54-week multicenter open-label study. Subjects and methods. The study enrolled 42 patients with AS who continued to have an active phase of the disea...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nikolay Vasil'evich Bunchuk, Oksana Alekseevna Rumyantseva, Elena Yur'evna Loginova, Anna Georgievna Bochkova, Gennadiy Ivanovich Storozhakov, Ol'ga Aleksandrovna Ettinger, Svetlana Dmitrievna Kosyura, Rimma Galimovna Kamalova, L M Valishina, N V Bunchuk, O A Rumyantseva, E Yu Loginova, A G Bochkova, G I Storozhakov, O A Ettinger, S D Kosyura, R G Kamalova
Formato:	Artigo
Idioma:	Russo
Publicado em:	"Consilium Medicum" Publishing house 2010-10-01
coleção:	Терапевтический архив
Assuntos:	ankylosing spondylitis treatment infliximab
Acesso em linha:	https://ter-arkhiv.ru/0040-3660/article/view/30685
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!